Genmab — September 2020
-
Tak til Pensionisten for link i går. Jorden begynder at blive lidt varm under fødder på disse: https://www.proinvestor.com/index.php?p=debat_1&postid=87155
-
Brian Durie om Teclistamab https://www.myeloma.org/videos/are-bispecific-antibodies-0
-
Rebalancering her ved slut på Q3.
-
Slutauktionerne kan være enorme på sådanne dage.
-
Det bliver den vist ikke i dag.
-
Jeps, men bevægelserne ses ofte også i dagene lige før.
-
-
89050 stk. Spændende om management har solgt nogle...
-
solgt = exercised
-
Ja selvfølgeligt, men er ikke særligt sandsynligt
-
The sale of shares by Jan van de Winkel is primarily to honor tax obligation arising out of his participation in Genmab A/S’ equity program in the income years 2017, 2018 and 2019. The sale of shares will take Jan van de Winkel’s personal holding of shares in Genmab A/S from 671,423 to 641,423 shares.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind